FTC sues drug middlemen over manipulating the insulin market
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in exchange for keeping lower-cost insulin off their lists of approved
Cigna Sues Federal Trade Commission Over ‘Defamatory’ Report
Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes pharmacy benefit managers and asked the court to order the agency to retract it.
FTC Sues CVS, Cigna, UnitedHealth Over Rising Insulin Costs (1)
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove up the price of insulin.
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
FTC Sues CVS Health, Cigna And United Health Group For Inflating Insulin Prices
The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's
American Pharmacists Association applauds FTC action on PBMs' alleged inflation of insulin drug prices
Hogue, PharmD, FAPhA, FNAP, FFIP, executive vice president and CEO of APhA, commended the Federal Trade Commission's (FTC) action today against alleged practices by large vertically integrated pharmacy benefit managers (PBMs) "for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
Cigna Group stock outperforms competitors despite losses on the day
Cigna Group closed $14.69 short of its 52-week high ($370.83), which the company reached on September 16th.
Cigna Demands FTC Retraction in Escalating Drug-Price Fight
The FTC report said the companies responsible for controlling spending on drugs were sometimes steering patients toward more ...
Yahoo Finance4d
The Cigna Group and Business Roundtable Host Workforce Mental Health Summit
18, 2024 /PRNewswire/ -- Business Roundtable and The Cigna Group brought together senior business executives, federal ...
Modern Healthcare3d
Cigna to cut Medicare Advantage plans in several states
Cigna is joining the chorus of health insurance companies detailing where they will scale back Medicare Advantage offerings ...
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
Cigna Group stock underperforms Wednesday when compared to competitors
Shares of Cigna Group CI slid 0.24% to $355.39 Wednesday, on what proved to be an all-around poor trading session for the ...
Business Insider9d
The Cigna Group Registered Shs
2022 The Cigna Group Registered Shs 4.48 1.35 USD 2021 The Cigna Group Registered Shs 4.00 1.74 USD 2020 The Cigna Group Registered Shs 0.04 0.02 USD 2019 The Cigna Group Registered Shs 0.04 0 ...
Morningstar4d
The Cigna Group and Business Roundtable Host Workforce Mental Health Summit
18, 2024 /PRNewswire/ -- Business Roundtable and The Cigna Group brought together senior business executives, federal policymakers and community leaders last night for a Workforce Mental Health ...
Cigna’s PBM Express Scripts sues the FTC, seeking retraction of drug-cost report
Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the ...
Yahoo Finance20h
The Cigna Group (CI)
The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices, claiming that they have been artificially ...